LINC02489: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

Target Name: LINC02489

NCBI ID: G101928919

LINC02489

Other Name(s): Long intergenic non-protein coding RNA 2489, transcript variant X1 | long intergenic non-protein coding RNA 2489 | LINC02489 variant X1

LINC02489: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

Abstract

LINC02489, a long intergenic non-protein-coding RNA (lncRNA), has been identified as a potential drug target and biomarker. It has been shown to be involved in various cellular processes, including cell adhesion, migration, and survival. The expression and function of LINC02489 have also been investigated in various disease contexts, such as cancer and neurodegenerative diseases. This review article will summarize the current understanding of LINC02489, including its potential as a drug target and biomarker.

LINC02489 is a transcribed RNA molecule that is longer than 200 nucleotides and is not covered by any protein coding genes. It has been identified as a long intergenic non-protein-coding RNA (lncRNA) and has been shown to play a role in various cellular processes, including cell adhesion, migration, and survival. LINC02489 has also been shown to be involved in various disease contexts, such as cancer and neurodegenerative diseases.

Potential Drug Target

The potential drug target for LINC02489 is its role in cell adhesion and migration. LINC02489 has been shown to be involved in the formation of tight junctions, which are a type of cell-cell adhesion, and has been shown to promote the migration of cancer cells. LINC02489 has also been shown to be involved in the regulation of the Notch signaling pathway, which is a key regulator of cell adhesion and migration.

Potential Biomarker

The potential biomarker for LINC02489 is its role in cancer and neurodegenerative diseases. LINC02489 has been shown to be overexpressed in various types of cancer, including breast cancer, lung cancer, and neuroblastoma. It has also been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

Current Research

LINC02489 has been shown to be involved in various cellular processes, including cell adhesion, migration, and survival. The expression and function of LINC02489 have also been investigated in various disease contexts, such as cancer and neurodegenerative diseases.

Conclusion

In conclusion, LINC02489 is a long intergenic non-protein-coding RNA that has been shown to play a role in various cellular processes, including cell adhesion, migration, and survival. Its potential as a drug target and biomarker is being investigated in various disease contexts. Further research is needed to fully understand the role of LINC02489 in disease progression and the development of new therapeutic approaches.

Protein Name: Long Intergenic Non-protein Coding RNA 2489

The "LINC02489 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02489 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets